- Home
- WTW vs A Comparison
WTW vs A Comparison
Compare WTW & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTW
- A
- Stock Information
- Founded
- WTW 1828
- A 1999
- Country
- WTW United Kingdom
- A United States
- Employees
- WTW N/A
- A N/A
- Industry
- WTW Specialty Insurers
- A Biotechnology: Laboratory Analytical Instruments
- Sector
- WTW Finance
- A Industrials
- Exchange
- WTW Nasdaq
- A Nasdaq
- Market Cap
- WTW 31.9B
- A 37.5B
- IPO Year
- WTW N/A
- A 1999
- Fundamental
- Price
- WTW $312.65
- A $127.06
- Analyst Decision
- WTW Buy
- A Buy
- Analyst Count
- WTW 15
- A 17
- Target Price
- WTW $313.93
- A $143.07
- AVG Volume (30 Days)
- WTW 678.3K
- A 1.9M
- Earning Date
- WTW 10-31-2024
- A 11-25-2024
- Dividend Yield
- WTW 1.13%
- A 0.74%
- EPS Growth
- WTW N/A
- A 25.91
- EPS
- WTW N/A
- A 4.81
- Revenue
- WTW $9,809,000,000.00
- A $6,497,000,000.00
- Revenue This Year
- WTW $5.66
- A N/A
- Revenue Next Year
- WTW $1.66
- A $5.30
- P/E Ratio
- WTW N/A
- A $26.40
- Revenue Growth
- WTW 5.58
- A N/A
- 52 Week Low
- WTW $234.01
- A $112.06
- 52 Week High
- WTW $320.77
- A $155.35
- Technical
- Relative Strength Index (RSI)
- WTW 64.20
- A 33.33
- Support Level
- WTW $314.54
- A $133.20
- Resistance Level
- WTW $318.85
- A $143.07
- Average True Range (ATR)
- WTW 5.43
- A 3.50
- MACD
- WTW 0.92
- A -0.54
- Stochastic Oscillator
- WTW 72.57
- A 7.19
About WTW Willis Towers Watson Public Limited Company
In January 2016, Towers Watson and Willis Group merged to form Willis Towers Watson, a global advisory, insurance brokerage, and solutions company. The company operates in two business segments: health, wealth, and career (its consulting operations) and risk and brokering (its brokerage operations). It has about 48,000 employees.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.